AUTHORS
Anjani Kapadia, M.D., Liam J. Schmitt, BA2, Rajit P. Hegde, BA3, Sang Mee Lee, PhD4, Austin Wesevich, MD, MPH, MS5, Lindsay Schwartz, M.D.6
AFFILIATIONS
1 University of Chicago, Chicago, Illinois, United States
2 University of Rochester, Rochester, New York, United States
3 University of Chicago, Chicago, Illinois, United States
4 University of Chicago, Chicago, Illinois, United States
5 Ohio State University, Columbus, Ohio, United States
6 Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, United States
ABSTRACT
Background: Adolescents and young adults (AYAs) with hematologic malignancies are frequently exposed to gonadotoxic therapies that may impair future fertility or result in adverse pregnancy outcomes (von Wolff, JMIR Res Protoc 2024). As survival outcomes improve, timely and high-quality fertility preservation (FP) discussions are an increasingly important component of comprehensive cancer care (Su, Cancer J 2019; Michalczyk, Cancers 2021). Although multiple safe and effective FP interventions are available (Su, 2025), they require prompt decision making under emotionally distressing conditions during a developmental stage in which identity and autonomy are still evolving. Prior studies have primarily evaluated FP counseling using decisional regret (Mack, Pediatrics 2019; Gonçalves, Cancers2021), but less is known about how patients experience the FP decision-making process itself and how those experiences are associated with patient-reported outcomes (PROs). Examining the roles of decision-making control (DMC) and shared decision making (SDM) may provide additional insight into patients’ experiences during FP decision making, yet their relationships with concurrent anxiety, depression, and health-related quality of life (HRQoL) remain poorly understood. In this study, we aim to evaluate associations between DMC and SDM during FP counseling with PROs among AYAs with hematologic malignancies.
Methods: We conducted a single-center, cross-sectional survey study of AYAs diagnosed with a hematologic malignancy between the ages of 18 and 39 receiving care through the University of Chicago AYA Oncology Program. Participants completed validated measures of DMC (Decision-Making Control Instrument), SDM (9-item Shared Decision Making Questionnaire), depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder-7), and HRQoL (36-item Short Form Health Survey). Surveys were completed as early as one month after diagnosis and as late as one year after completing treatment to minimize recall bias. Demographic, clinical and FP counseling characteristics were collected by survey and electronic medical record review. Descriptive statistics were used to summarize patient characteristics, and characteristics were compared according to FP pursuit using chi-square and Fisher's exact tests. Associations between decision-making measures and PROs were evaluated using univariate linear regression models.
Results: Among 51 AYAs surveyed, 27 (53%) identified as cis-gender male, 21 (41%) as cis-gender female, and 3 (6%) as other gender identities. The median age at diagnosis was 24.7 years (IQR 21.4 – 33.4), and 21 (41%) pursued FP. Patients who pursued FP were less likely to be insured through Medicaid (10% vs 36%; p=0.047). Patients who pursued FP also tended to be younger at diagnosis, White, have higher educational attainment, and have fewer children, although these differences did not reach statistical significance (all p > 0.05). Greater FP DMC was associated with lower depression (β= -0.23, p=0.014) and anxiety (β= -0.23, p=0.019), as well as better self-reported vitality (β= 0.57, p=0.003), emotional well-being (β= 0.75, p < 0.001), and social functioning (β= 0.50, p=0.008). These associations were primarily driven by the Absence of Control subscale of the DMC instrument. In contrast, SDM was not significantly associated with depression, anxiety, or HRQoL.
Conclusion: Greater DMC during FP counseling was associated with lower levels of depression and anxiety and improved psychosocial HRQoL. The strongest associations were observed for the Absence of Control subscale, suggesting that feeling engaged and empowered during FP decision-making may be particularly important to psychosocial well-being. These findings demonstrate the importance of patient agency when making critical and personal decisions and highlight DMC as a potential target to improve psychosocial wellbeing as it relates to FP counseling. Identifying individual-, interpersonal-, and systems-level factors that shape FP DMC could subsequently inform the development of interventions, such as decision-aids, values clarification tools, and other patient-centered supports. Future studies in larger, more diverse patient populations will seek to validate these findings, establish causal relationships, and determine whether improvements in DMC translate into improved psychosocial well-being and other patient-centered outcomes.
DISCLOSURES
Anjani Kapadia, M.D.: No relevant conflicts of interest to declare.